mRNA Injection Restores Cohesin Regulator Halving Aneuploidy Rate in Human Oocytes Over Age 35
Targeted mRNA delivery halves meiotic error in aged human eggs by replenishing a cohesin subunit whose natural decline is a primary driver of age-related infertility. The finding reframes reproductive aging as a potentially reversible protein-dosage problem rather than an inevitable cellular clock. Rigorous functional and safety studies in intact embryos remain essential before clinical translation.
The study cultured 120 discarded human oocytes and used live-cell imaging plus array CGH to quantify aneuploidy before and after microinjection of in-vitro-transcribed mRNA encoding the cohesin loader SMC1B. Error rates fell from 48 % to 24 % in the treated cohort while spindle morphology and polar-body extrusion remained comparable to younger controls.
Aneuploidy drives >60 % of IVF miscarriages after 38 and is the dominant reason mean maternal age at first birth has risen without parallel fertility gains. Prior work linked cohesin decay to premature separation of sister chromatids; the present intervention directly tests whether transient restoration of one subunit is rate-limiting.
Because the work used non-viable oocytes and lacked functional fertilization or embryo-transfer endpoints, it cannot yet speak to live-birth rates or long-term offspring safety. The next required step is a GLP-compliant primate study measuring blastocyst euploidy and implantation before any human safety trial can be justified.
GLP primate study: blastocyst euploidy will rise above 65 % in treated versus 35 % in vehicle controls within 18 months of protocol approval.
Sources (2)
- [1]Primary Source(https://www.cell.com/developmental-cell/fulltext/S1534-5807(24)00312-8)
- [2]Supporting Source(https://www.nature.com/articles/s41556-023-01182-4)